Scienture Holdings, Inc. announces entering into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting fees and expenses.
The offering, expected to close on August 15, 2025, is under the supervision of Maxim Group LLC as the sole placement agent.
Offering Details
3,225,000 shares of common stock to be purchased at $1.20 per share.
Gross Proceeds
Approximately $3.9 million expected before deductions.
Closing Date
The offering is set to close on August 15, 2025.
- Scienture Holdings aims to enhance value to patients, physicians, and caregivers through novel specialty products.
- Maxim Group LLC's role as the placement agent emphasizes the professional handling of the offering.
The registered direct offering signifies Scienture Holdings' strategic move to raise funds for further business development and market expansion.